Ridgetech Inc. current report, Q1 FY2022

Filing Overview

The March 23, 2022 Form 6-K was filed by China Jo-Jo Drugstores, Inc., a Cayman Islands company, for the month of March 2022. The request metadata identifies Ridgetech Inc., but the filing itself identifies China Jo-Jo Drugstores, Inc.; this discrepancy should be verified.

Business and Reporting Context

The filing reports the results of the company’s March 18, 2022 Extraordinary General Meeting of Shareholders. A quorum was present, and shareholders approved three proposals concerning a reverse stock split, an increase in authorized share capital, and related amendments to the company’s constitutional documents.

Key Financial and Capitalization Information

  • The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or operating performance metrics.
  • Shareholders approved a one-for-twelve reverse stock split of the company’s issued and outstanding ordinary shares.
  • Before the proposed capitalization change, authorized share capital was stated as US$510,000, comprising 41,666,667 ordinary shares with a US$0.012 par value and 10,000,000 preferred shares with a US$0.001 par value.
  • Authorized share capital will increase to US$6,010,000, comprising 500,000,000 ordinary shares with a US$0.012 par value and 10,000,000 preferred shares with a US$0.001 par value.
  • The proposals create an additional 458,333,333 authorized ordinary shares, ranking pari passu with existing ordinary shares.

Voting Results and Material Changes

ProposalForAgainstAbstain
One-for-twelve reverse stock split18,645,753256,37192,465
Authorized share capital increase18,056,264840,71497,611
Amended and restated memorandum and articles18,036,629695,967261,993

All three proposals were approved. The amendments include changes to clause 8 of the Memorandum of Association and clause 3(1) of the Articles of Association.

Implementation, Outlook, and Risks

  • The reverse stock split will occur at a time and date determined by the board in its discretion, if implemented.
  • The capital increase and amended constitutional documents are subject to implementation of the relevant proposals by the board.
  • The filing provides no financial guidance or operating outlook.
  • The reverse split and expanded authorized share count may materially affect the company’s share structure, potential future issuances, and existing shareholders’ percentage ownership.

Investor Verification Items

  • Verify the issuer’s identity because the supplied metadata names Ridgetech Inc., while the filing names China Jo-Jo Drugstores, Inc.
  • Confirm the effective date and treatment of fractional shares, if any, under the one-for-twelve reverse stock split.
  • Confirm whether and when the board implemented the reverse split and authorized share capital increase.
  • Assess the potential dilution implications of the 458,333,333 additional authorized ordinary shares.
  • Review subsequent filings for the final amended memorandum and articles and any post-split share counts.